Estrella leads her group and is responsible for clinical trials worldwide. Since Almirall do not have affiliates fully involved in clinical development, the company externalizes all clinical trials, with a strategic focus on keeping only core competencies. In this capacity Estrella has worked with dozens of CROs and service providers managing Phase I to Phase IV clinical trials of all sizes, from small single centre studies to global programs involving hundreds of sites and thousands of patients. Her responsibility is covering the selecting, negotiation, contracting, managing and final evaluation of the CROs responsible for the worldwide clinical development, in order to deliver on the agreed timelines, quality and cost.
She was responsible for ensuring Clinical Development for Aclidinium bromide from Operational point of view in COPD.
Since November 2014, fully focus on DERMATOLOGY development with 3 R&D sites in Europe, the biggest in Barcelona (Sant Feliu de Llobregat), the second in Reinbek and the most recent the one adquire in Swizerlan -Lugano- (Polichem). But also in close collaboration with Almirall US, company that it was acquired by Almirall back in December 2013 (AQUA Pharmaceuticals).
Managing Global Clinical Trials from Phase I to Phase IV, in several therapeutical areas Respiratory, Dermatology, Migrain, Allergy and Gastrointestinal. CRO Selection and Management. Deliverables in Clinical Trials. Metrics and Performance in Clinical trials
Arena’s business-to-business events offer a myriad of opportunities for sponsors and exhibitors to drive their businesses forward.
Our sponsorship packages help companies educate ther target market on key industry issues and spread brand awareness throughout the
If you want to discuss how we can help you generate leads and add-value to your corporate and brand image please contact:
+44 (0)20 7936 6948